분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-03-23 13:01:09 , Hit : 844
 Using Gene Editing to Delete HIV from Human T Cells

GEN News Highlights

Mar 22, 2016

Researchers at Temple University used a CRISPR gene editing technique to remove HIV from the DNA of human cells grown in culture. Their study ("Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing") is published In Scientific Reports.

According to senior investigator on the new study, Kamel Khalili, Ph.D., Laura H. Carnell Professor and Chair of the Department of Neuroscience, Director of the Center for Neurovirology, and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University (LKSOM), "Antiretroviral drugs are very good at controlling HIV infection. But patients on antiretroviral therapy who stop taking the drugs suffer a rapid rebound in HIV replication." The presence of numerous copies of HIV weakens the immune system and eventually causes acquired immune deficiency syndrome, or AIDS.

Curing HIV/AIDS, which has claimed the lives of more than 25 million people since it was first discovered in the early 1980s, is the ultimate goal in HIV research. But eliminating the virus after it has become integrated into CD4+ T cells, the cells primarily infected with HIV, has proven difficult. Recent attempts have focused on intentionally reactivating HIV, aiming to stimulate a robust immune response capable of eradicating the virus from infected cells. However, to date, none of these "shock-and-kill" approaches has been successful.

Dr. Khalili and colleagues decided to try a different approach, specifically targeting HIV-1 proviral DNA using uniquely tailored gene editing technology. Their system includes a guide RNA that specifically locates HIV-1 DNA in the T cell genome, and a nuclease enzyme, which cuts the strands of T-cell DNA. Once the nuclease has edited out the HIV-1 DNA sequence, the loose ends of the genome are reunited by the cell's own DNA repair machinery.

In previous work, Dr. Khalili's team had demonstrated the ability of their technology to snip out HIV-1 DNA from human cell lines. In their latest study, however, they concentrated on latently and productively infected CD4+ T cells to show not only that the technology eliminates the virus from cells but also that its persistent presence in HIV-1–eradicated cells actually protects them against reinfection. More importantly, they carried their work over to ex vivo experiments in which T cells from patients infected with HIV were grown in cell culture, showing that treatment with the gene editing system can suppress viral replication and dramatically reduce viral load in patient cells.

In another major component of the study, Dr. Khalili's team addressed questions about off-target effects and toxicity. Using an approach known as ultra-deep whole-genome sequencing, which is considered the gold standard for genomic assessment, the researchers analyzed the genomes of HIV-1–eradicated cells for mutations in genes outside the region targeted by the guide RNA. Their analyses ruled out off-target effects on genes, including potential collateral effects on cellular gene expression. Studies of cell viability and proliferation showed that HIV-1–eradicated cells were growing and functioning normally.

"The findings are important on multiple levels," Dr. Khalili said. "They demonstrate the effectiveness of our gene editing system in eliminating HIV from the DNA of CD4 T cells and, by introducing mutations into the viral genome, permanently inactivating its replication. Further, they show that the system can protect cells from reinfection and that the technology is safe for the cells, with no toxic effects."

"These experiments had not been performed previously to this extent," he added. "But the questions they address are critical, and the results allow us to move ahead with this technology."








1207   Outsourcing Gene Editing to the Public-Online Game Challenges Players to Design CRISPR On/Off Switch  이성욱 2017/09/05 795
1206   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 801
1205   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 804
1204   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 809
1203   Uncovering Functions of Circular RNAs  이성욱 2017/08/14 809
1202   Zika Update  이성욱 2016/03/15 814
1201   CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 820
1200   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 821
1199   CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 833
1198   First In Vivo Human Genome Editing to Be Tested in New Clinical Trial  이성욱 2017/05/18 841
  Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 844
1196   유전자치료제 '인보사' 연골재생 입증못해도 허가받은 까닭  이성욱 2017/07/14 845
1195   [바이오토픽] FDA 자문위원회, CAR-T(chimeric antigen receptor T cell) 승인 만장일치로 권고  이성욱 2017/07/14 848
1194   First In Vivo Function Found for Animal Circular RNA  이성욱 2017/08/14 850
1193   ‘단세포 인공생명체’ 눈앞에 성큼  이성욱 2017/03/11 855
1192   Revisiting CAR T-Cells for Treating HIV Shows Promise  이성욱 2016/07/19 858
1191   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 861
1190   CRISPR Can Tag RNA  이성욱 2016/03/26 867
1189   유전자 가위로 바이러스 제거한 '청정 돼지' 나왔다  이성욱 2017/08/24 868
1188   독감바이러스의 ‘RNA 도둑질’  이성욱 2017/05/08 869

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2023 Zeroboard / skin by ROBIN